Institute for Global Pharmaceutical Development

The Institute for Global Pharmaceutical Development (IGPD) will be an independent, free-standing, non-profit (501C3) organization whose mission is to conduct research and offer programs that will enable the pharmaceutical industry to accelerate the development of and access to new medications.

The IGPD will be affiliated with three founding partners: the University of Arizona (UA), SRI International (formerly known as the Stanford Research Institute), and the United States Food and Drug Administration (FDA).

Each partner contributes unique strengths to the IGPD. The UA will provide the academic home and infrastructure for the IGPD's educational and research programs and an environment of innovation and inquiry. The participating FDA scientists will provide the first hand knowledge of the regulatory process and a wealth of experience in the evaluation of new pharmaceutical agents. SRI will bring practical experience in pharmaceutical development, scientific expertise, and a track record of commercializing new drugs.

More here.